scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0162-3109(98)00021-6 |
P698 | PubMed publication ID | 9754904 |
P2093 | author name string | T C Peterson | |
R Isbrucker | |||
G Slysz | |||
P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability | Q29617252 | ||
Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate | Q30464735 | ||
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy | Q34173602 | ||
Platelet-derived growth factor and its role in health and disease | Q37583401 | ||
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis | Q39514969 | ||
Effect of ingested pentoxifylline on neutrophil superoxide anion production | Q40152029 | ||
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists | Q41433205 | ||
Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties | Q41543325 | ||
Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors | Q42521668 | ||
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells | Q42580701 | ||
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
Cyclic AMP-Independent Inhibition of Voltage-Sensitive Calcium Channels by Forskolin in PC12 Cells | Q58214003 | ||
Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells | Q61763100 | ||
Fibroproliferation in liver disease: role of monocyte factors | Q67743304 | ||
Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes | Q68019505 | ||
Immunomodulatory effects of ursodeoxycholic acid on immune responses | Q68225187 | ||
Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients | Q68496172 | ||
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx | Q71569068 | ||
Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism | Q71663164 | ||
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid | Q72189521 | ||
Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling | Q72240000 | ||
Expression of platelet-derived growth factor in a model of acute liver injury | Q72271873 | ||
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation | Q72310404 | ||
Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells | Q73574969 | ||
Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts | Q74345557 | ||
P433 | issue | 3 | |
P921 | main subject | pentoxifylline | Q416331 |
P304 | page(s) | 181-191 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Immunopharmacology | Q24031542 |
P1476 | title | The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. | |
P478 | volume | 39 |
Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
Q36197335 | Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. |
Q35592380 | Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. |
Q33723536 | Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases |
Q43263224 | The role of adenosine receptors in the action of theophylline on human peripheral blood mononuclear cells from healthy and asthmatic subjects. |
Q51420049 | Xanthines and Phosphodiesterase Inhibitors. |
Search more.